• News
  • Events
  • About Us
  • Support
  • Contact
  • Purchase

linkedin
rss
twitter
vimeo
youtube
google_plus

  • Home
  • Core Technology
  • Targeted DNA Sequencing
    • Systems
      • ThunderStorm™ System
      • RDT 1000
    • Workflow
    • Applications
      • Cancer Research Solutions
      • Medical Genetics Solutions
      • Rare Cancer Mutation Detection: DeepSeq FFPE
      • Targeted Methylation Analysis: MethylSeq
    • Gene Panels
      • ASDSeq™ Panel
      • Cancer Hotspot Panel
      • ADMESeq™ Panel
      • HLASeq™ Panel
      • ONCOSeq™ Panel
      • XSeq™ Panel
    • Service Partner Program
      • Ambry Genetics
      • Emory Genetics Laboratory
      • GeneDx
      • Greenwood Genetic Center
    • Consumables
  • Digital PCR
    • System
      • RainDrop™ System
    • Applications
      • Copy Number Variation
      • Low-Frequency Tumor Allele
    • Consumables
  • Customers
    • All Customer Profiles
    • Webinars
    • Targeted DNA Sequencing Customers
    • Digital PCR Customers
    • Service Partner Program
  • Publications
    • Peer-Reviewed Articles
      • Targeted DNA Sequencing Articles
      • Digital PCR Articles
      • Technology Reviews
      • Microdroplet Applications Articles
    • Scientific Posters
      • Targeted DNA Sequencing Posters
      • Digital PCR Posters
  • Blog



Assessment of Target Enrichment Platforms Using Massively Parallel Sequencing for the Mutation Detection for Congenital Muscular Dystrophy

January 18, 2012
by RDT
Comments are off

Assessment of Target Enrichment Platforms Using Massively Parallel Sequencing for the Mutation Detection for Congenital Muscular Dystrophy
C.A. Valencia,, D. Rhodenizer, S. Bhide, E. Chin, M.R.Littlejohn, L.M. Keong, A. Rutkowski, C. Bonnemann, M. Hegde. Jol of Molecular Diagnostics 2012; doi:10.1016/j.jmoldx.2012.01.009.


Related posts:

  • Targeted polymerase chain reaction-based enrichment and next generation sequencing for diagnostic testing of congenital disorders of glycosylation
  • Mutation screening in 86 known X-linked mental retardation genes by droplet-based multiplex PCR and massive parallel sequencing
  • Targeted sequencing of the human X chromosome exome
About the Author
Social Share
  • google-share

Publications

  • Publications
  • Peer-Reviewed Articles
    • Targeted DNA Sequencing Articles
    • Digital PCR Articles
    • Technology Reviews
    • Microdroplet Applications Articles
  • Scientific Posters
    • Targeted DNA Sequencing Posters
    • Digital PCR Posters

About RainDance Technologies

RainDance Technologies is pioneering digital biology and powering ground-breaking human health and life science research with its novel droplet-based technologies. The power, precision and simplicity of picodroplets enable researchers to answer complex questions with unprecedented sensitivity and quantitation.

Receive Our Updates



© 2006–2013 RainDance Technologies, Inc. All rights reserved.
Contact – Terms of Use – Privacy Policy – Legal – Site Map